APT Pharmaceuticals

company

About

APT Pharmaceuticals is a drug-development company focused on treatments for significant unmet medical needs.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$22M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2005
Number Of Employee
11 - 50
Operating Status
Active

APT Pharmaceuticals is a drug development company focused on repurposing well-characterized drugs for under-served populations.
APT’s initial focus is on the pulmonary delivery of treatments for serious lung diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$54M
APT Pharmaceuticals has raised a total of $54M in funding over 2 rounds. Their latest funding was raised on Sep 30, 2008 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 30, 2008 Series B $32M 1 Detail
Oct 5, 2007 Series A $22M 1 Versant Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
APT Pharmaceuticals is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Series B